|
LARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.087600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.371200E-01 |
| Normal-vs-Stage2 |
5.588200E-01 |
| Normal-vs-Stage3 |
3.414800E-01 |
| Normal-vs-Stage4 |
4.056000E-01 |
| Stage1-vs-Stage2 |
8.341600E-01 |
| Stage1-vs-Stage3 |
8.268000E-01 |
| Stage1-vs-Stage4 |
1.435220E-01 |
| Stage2-vs-Stage3 |
7.103000E-01 |
| Stage2-vs-Stage4 |
3.052000E-01 |
| Stage3-vs-Stage4 |
1.652620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.440800E-01 |
| Normal-vs-AfricanAmerican |
1.333230E-01 |
| Normal-vs-Asian |
6.325200E-01 |
| Caucasian-vs-AfricanAmerican |
3.479000E-01 |
| Caucasian-vs-Asian |
9.518200E-01 |
| AfricanAmerican-vs-Asian |
7.862400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.089600E-02 |
| Normal-vs-Female |
1.640230E-01 |
| Male-vs-Female |
2.084400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.820000E-01 |
| Normal-vs-Extreme_Weight |
1.344960E-01 |
| Normal-vs-Obese |
6.976600E-01 |
| Normal-vs-Extreme_Obese |
2.223800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.159200E-01 |
| Normal_Weight-vs-Obese |
7.456000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.242600E-01 |
| Extreme_Weight-vs-Obese |
3.507000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.936000E-01 |
| Obese-vs-Extreme_Obese |
3.098600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.526000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.679600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.246500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.191420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.873000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.683600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.330020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.075900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.225400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.581600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.099800E-02 |
| Normal-VS-Type2 PRCC |
7.169800E-01 |
| Normal-VS-KIRP CIMP |
9.270200E-01 |
| Normal-VS-Unclassified PRCC |
4.170000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.241200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.205200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.359600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.013000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.984000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.243800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.158000E-02 |
| Normal-vs-N1 |
7.542800E-01 |
| Normal-vs-N2 |
8.643000E-01 |
| N0-vs-N1 |
1.508800E-01 |
| N0-vs-N2 |
7.562600E-01 |
| N1-vs-N2 |
7.446000E-01 |
|
|
